Trends in adjuvant development for vaccines: DAMPs and PAMPs as potential new adjuvants
Open accessAbstract
Aluminum salts have been widely used in vaccine formulations and, after their introduction more than 80 years ago, only few vaccine formulations using new adjuvants were developed in the last two decades. Recent advances in the understanding of how innate mechanisms influence the adaptive immunity opened up the possibility for the development of new adjuvants in a more rational design. The purpose of this review is to discuss the recent advances in this field regarding the attempts to determine the molecular basis and the general mechanisms underlying the development of new adjuvants, with particular emphasis on the activation of receptors of innate immune recognition. One can anticipate that the use of these novel adjuvants will also provide a window of opportunities for the development of new vaccines.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The addition of PAMPs to a subunit vaccine, triggering their corresponding pattern-recognition receptors (e.g., TLRs), improves vaccine efficacy in older humans and mice.
“On the other hand, the addition of PAMPs to a subunit vaccine, triggering their corresponding pattern-recognition receptors (e.g., TLRs) improves vaccine efficacy in older humans and mice (25, 30–32).”
From Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention (2019) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Kawai, T., & Akira, S. (2010) · Nature Immunology · doi:10.1038/ni.1863 · Cited by 9,304 · cited 3× · see citing works
“The TLRs11-13 have been lost from the human genome (13).”
BackgroundAkira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312 · cited 2× · see citing works
“Mice do not present a functional TLR10 due to an insertional mutagenesis of a retrovirus but have additional TLRs (TLRs11-13), besides those in common with man (TLRs1-9).”
BackgroundMartinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066 · cited 1× · see citing works
“The recruitment of procaspase-1 by NLRP3 is mediated by another molecule, apoptosis-associated speck-like (ASC) protein containing a CARD, via interaction with the NLRP3 pyrin domain, resulting in the multimeric structure of the inflammasome (Figure 3) (26,27).”
BackgroundSchroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475 · see citing works
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
Mogensen, T. H. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00046-08 · Cited by 3,122 · cited 1× · see citing works
“Activation of the inflammasome by molecules recognized by NLRP3 will catalyze the processing of the IL-1β precursor induced by TLR-dependent mechanisms (26,30-32).”
BackgroundHornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065 · cited 11× · see citing works
“Whereas stimulation of NOD1 and NOD2 (Figure 1), members of the NLR family, results primarily in the activation of the pro-inflammatory gene expression response (25), other NLRs (like NLRP3), activate the caspase-1 that processes the inactive IL-1β and IL-18 precursors and eventually results in the secretion of the IL…”
BackgroundInfluentialThe Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436 · cited 1× · see citing works
“NLRs include a large family of intracellular sensors that can detect both pathogens and stress signals (24).”
BackgroundVaccine Adjuvants: Putting Innate Immunity to Work
Coffman, R. L., Sher, A., & Seder, R. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.002 · Cited by 1,927 · cited 1× · see citing works
“It leads to a very high antibody response with a Th2 profile against the antigen in mice, and in humans the immune response tends to be a mix of Th2 and Th1 cells (39,40).”
BackgroundThe Inflammasome NLRs in Immunity, Inflammation, and Associated Diseases
Davis, B. K., Wen, H., & Ting, J. P.-Y. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101405 · Cited by 1,618 · cited 1× · see citing works
“Activation of the inflammasome by molecules recognized by NLRP3 will catalyze the processing of the IL-1β precursor induced by TLR-dependent mechanisms (26,30-32).”
BackgroundCrucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542 · cited 11× · see citing works
“Whereas stimulation of NOD1 and NOD2 (Figure 1), members of the NLR family, results primarily in the activation of the pro-inflammatory gene expression response (25), other NLRs (like NLRP3), activate the caspase-1 that processes the inactive IL-1β and IL-18 precursors and eventually results in the secretion of the IL…”
BackgroundInfluentialKawai, T., & Akira, S. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2006.12.004 · Cited by 1,404 · cited 1× · see citing works
“In this pathway, the transcription factor interferon regulatory factor 5 is also activated and translocated to the nucleus and binds to interferon-stimulated response element regions present in the promoter segments of pro-inflammatory cytokines (13,21).”
BackgroundFranchi, L., Amer, A., Body-Malapel, M., Kanneganti, T.-D., Özören, N., Jagirdar, R., Inohara, N., Vandenabeele, P., Bertin, J., Coyle, A., et al. (2006) · Nature Immunology · doi:10.1038/ni1346 · Cited by 1,131 · cited 1× · see citing works
“Bacterial flagellin is recognized by TLR5 and cytosolic and monomeric flagellin is recognized by Ipaf from the NLR innate system (33,34).”
BackgroundCytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf
Miao, E. A., Alpuche-Aranda, C. M., Dors, M., Clark, A. E., Bader, M. W., Miller, S. I., & Aderem, A. (2006) · Nature Immunology · doi:10.1038/ni1344 · Cited by 1,127 · cited 1× · see citing works
“Bacterial flagellin is recognized by TLR5 and cytosolic and monomeric flagellin is recognized by Ipaf from the NLR innate system (33,34).”
BackgroundHelical Assembly in the MyD88-IRAK4-IRAK2 Complex in TLR/IL-1R Signalling
Lin, S.-C., Lo, Y.-C., & Wu, H. (2010) · Nature · doi:10.1038/nature09121 · Cited by 1,111 · cited 1× · see citing works
“The first one involves the adaptor molecules TIRAP and MyD88 when pathogen-induced dimerization of TLR4 recruits MyD88 molecules and IRAK kinase enzymes that hierarchically assemble into a left-handed helical oligomerized tower for proper signal transduction, triggering NF-κB activation and pro-inflammatory cytokine g…”
BackgroundIntracellular NOD-like Receptors in Host Defense and Disease
Kanneganti, T., Lamkanfi, M., & Núñez, G. (2007) · Immunity · doi:10.1016/j.immuni.2007.10.002 · Cited by 1,056 · cited 1× · see citing works
“Whereas stimulation of NOD1 and NOD2 (Figure 1), members of the NLR family, results primarily in the activation of the pro-inflammatory gene expression response (25), other NLRs (like NLRP3), activate the caspase-1 that processes the inactive IL-1β and IL-18 precursors and eventually results in the secretion of the IL…”
BackgroundIntegral role of IRF-5 in the gene induction programme activated by Toll-like receptors
Takaoka, A., Yanai, H., Kondo, S., Duncan, G. S., Negishi, H., Mizutani, T., Kano, S., Honda, K., Ohba, Y., Mak, T. W., et al. (2005) · Nature · doi:10.1038/nature03308 · Cited by 1,042 · cited 1× · see citing works
“Interestingly, interferon regulatory factor 5 is involved in the transcription of proinflammatory cytokines by all TLRs tested so far (22).”
BackgroundToll‐like Receptor and RIG‐1‐like Receptor Signaling
Kawai, T., & Akira, S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.020 · Cited by 985 · cited 1× · see citing works
“Other interesting reviews on RLRs or CLRs can be found elsewhere (6-12).”
BackgroundDAMPening Inflammation by Modulating TLR Signalling
Piccinini, A. M., & Midwood, K. S. (2010) · Mediators of Inflammation · doi:10.1155/2010/672395 · Cited by 974 · cited 1× · see citing works
“PR OV IS IO NA L findings are contributing to the understanding of how exogenous and endogenous factors activate TLRs and, although some evidence shows some overlap in the molecular machinery, DAMPs present some distinct mechanisms to PAMPs, resulting in different outcomes (19).”
BackgroundProgramming the magnitude and persistence of antibody responses with innate immunity
Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Tang, H., Nakaya, H. I., Ravindran, R., Stewart, S. M., Alam, M. S., Kwissa, M., et al. (2011) · Nature · doi:10.1038/nature09737 · Cited by 970 · cited 1× · see citing works
“Therefore, new trends in vaccine developments include the use of new adjuvants (PAMPs or DAMPs) based on new PRR agonists as well as the combination of these adjuvants, aiming at the programming of the magnitude and persistence of the desired immune response (55).”
BackgroundThe Vaccine Adjuvant Monophosphoryl Lipid A as a TRIF-Biased Agonist of TLR4
Mata‐Haro, V., Cekic, C., Martin, M., Chilton, P. M., Casella, C. R., & Mitchell, T. C. (2007) · Science · doi:10.1126/science.1138963 · Cited by 901 · cited 2× · see citing works
“It is interesting to note that while binding of LPS to TLR4 activates both the MyD88-TIRAP and TRIF-TRAM pathways (Figure 2), MPL was shown to activate only the TRIFTRAM pathway, which accounts for its adjuvant properties and low toxicity (23).”
BackgroundThe Evolution of Adaptive Immune Systems
Cooper, M. D., & Alder, M. N. (2006) · Cell · doi:10.1016/j.cell.2006.02.001 · Cited by 875 · cited 1× · see citing works
“The innate immune system is phylogenetically more ancient and is the first line of defense (5), being able to induce a rapid and nonspecific response to the encounter of a pathogen, in contrast to the adaptive immune system, which depends on B and T lymphocytes.”
BackgroundStoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870 · cited 1× · see citing works
“The use of AS02, an oil (squalene)-in-water emulsion of monophosphoryl lipid and the saponin QS21, has led to some level of protection in immunized individuals (53).”
BackgroundLeucine-rich repeats and pathogen recognition in Toll-like receptors
Bell, J. K., Mullen, G. E. D., Leifer, C. A., Mazzoni, A., Davies, D. R., & Segal, D. M. (2003) · Trends in Immunology · doi:10.1016/s1471-4906(03)00242-4 · Cited by 766 · cited 1× · see citing works
“Thirteen TLRs have been identified in mammals, which can recognize many structurally different ligands through their distinct extra-domain (13,14).”
BackgroundDidierlaurent, A. M., Morel, S., Lockman, L., Giannini, S. L., Bisteau, M., Carlsen, H., Kielland, A., Vosters, O., Vanderheyde, N., Schiavetti, F., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901474 · Cited by 757 · cited 2× · see citing works
“It leads to a very high antibody response with a Th2 profile against the antigen in mice, and in humans the immune response tends to be a mix of Th2 and Th1 cells (39,40).”
BackgroundHicks, L. A., Harrison, L. H., Flannery, B. L., Hadler, J. L., Schaffner, W., Craig, A. S., Jackson, D. M., Thomas, A. R., Beall, B., Lynfield, R., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/521626 · Cited by 736 · cited 1× · see citing works
“Current pneumococcal conjugate vaccines are able to reduce both carriage and invasive disease caused by serotypes included in the formulations; however, the replacement of prevalent serotypes with non-vaccine serotypes has taken place and has led to reduced efficacy after some years of widespread use in children (59,6…”
BackgroundCutting Edge: Inflammasome Activation by Alum and Alum’s Adjuvant Effect Are Mediated by NLRP3
Li, H., Willingham, S. B., Ting, J. P. ‐., & Re, F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.17 · Cited by 674 · cited 11× · see citing works
“Whereas stimulation of NOD1 and NOD2 (Figure 1), members of the NLR family, results primarily in the activation of the pro-inflammatory gene expression response (25), other NLRs (like NLRP3), activate the caspase-1 that processes the inactive IL-1β and IL-18 precursors and eventually results in the secretion of the IL…”
BackgroundInfluentialSingleton, R. J., Hennessy, T. W., BULKOW, L. R., Hammitt, L. L., Zulz, T., Hurlburt, D. A., Butler, J. C., Rudolph, K. M., & Parkinson, A. J. (2007) · JAMA · doi:10.1001/jama.297.16.1784 · Cited by 615 · cited 1× · see citing works
“Current pneumococcal conjugate vaccines are able to reduce both carriage and invasive disease caused by serotypes included in the formulations; however, the replacement of prevalent serotypes with non-vaccine serotypes has taken place and has led to reduced efficacy after some years of widespread use in children (59,6…”
BackgroundKool, M., Pétrilli, V., Smedt, T. D., Rolaz, A., Hammad, H., van Nimwegen, M., Bergen, I. M., Castillo, R., Lambrecht, B. N., & Tschopp, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3755 · Cited by 612 · cited 11× · see citing works
“Whereas stimulation of NOD1 and NOD2 (Figure 1), members of the NLR family, results primarily in the activation of the pro-inflammatory gene expression response (25), other NLRs (like NLRP3), activate the caspase-1 that processes the inactive IL-1β and IL-18 precursors and eventually results in the secretion of the IL…”
BackgroundInfluentialTargeting the innate immune response with improved vaccine adjuvants
Pashine, A., Valiante, N. M., & Ulmer, J. B. (2005) · Nature Medicine · doi:10.1038/nm1210 · Cited by 554 · see citing works
Querec, T. D., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K. B., Flavell, R. A., Akira, S., Ahmed, R., & Pulendran, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051720 · Cited by 552 · cited 3× · see citing works
“In vivo, immunization of MyD88-/- mice with YF17D led to diminished numbers of CD4+ and CD8+ T cells expressing IFN-γ (37).”
BackgroundDuncan, J. A., Bergstralh, D. T., Wang, Y., Willingham, S. B., Ye, Z., Zimmermann, A. G., & Ting, J. P.-Y. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611496104 · Cited by 503 · cited 1× · see citing works
“Interestingly, NLRP3 directly binds ATP and mutation of the nucleotide-binding domain of NLRP3 reduces ATP binding, caspase-1 activation, IL-1 production, cell death, macromolecular complex formation, self-association, and association with the inflammasome component ASC, suggesting a crucial role of ATP in inflammasom…”
BackgroundYoon, S.-Y. H. (1964) · Forest History Newsletter · doi:10.1177/003754976400200402 · Cited by 493 · cited 1×
“Though several developed countries have now replaced it with an acellular formulation composed of purified proteins from Bordetella pertussis, the Pan American Health Organization concluded that there is no reason for Latin American countries to change from cellular to acellular vaccines based on safety and costeffect…”
BackgroundFranchi, L., & Núñez, G. (2008) · European Journal of Immunology · doi:10.1002/eji.200838549 · Cited by 452 · cited 11× · see citing works
“Whereas stimulation of NOD1 and NOD2 (Figure 1), members of the NLR family, results primarily in the activation of the pro-inflammatory gene expression response (25), other NLRs (like NLRP3), activate the caspase-1 that processes the inactive IL-1β and IL-18 precursors and eventually results in the secretion of the IL…”
BackgroundInfluentialEfficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of Age
Bejon, P., Lusingu, J., Olotu, A., Leach, A. J., Lievens, M., Vekemans, J., Mshamu, S., Lang, T. A., Gould, J. H. M., Dubois, M., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0807381 · Cited by 415 · cited 2× · see citing works
“The use of AS02, an oil (squalene)-in-water emulsion of monophosphoryl lipid and the saponin QS21, has led to some level of protection in immunized individuals (53).”
ResultNew adjuvants for human vaccines
Mbow, M. L., Gregorio, E. D., Valiante, N. M., & Rappuoli, R. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.04.004 · Cited by 408 · cited 1× · see citing works
“Nevertheless, alum is a poor inducer of protective Th1-associated immune response, an important feature for the development of vaccines against intracellular pathogens (41).”
BackgroundC-type lectin receptors on dendritic cells and langerhans cells
Figdor, C., van Kooyk, Y., & Adema, G. (2002) · Nature reviews. Immunology · doi:10.1038/nri827 · Cited by 383 · cited 1×
“Other interesting reviews on RLRs or CLRs can be found elsewhere (6-12).”
BackgroundAluminum Hydroxide Adjuvants Activate Caspase-1 and Induce IL-1β and IL-18 Release
Li, H., Nookala, S., & Re, F. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.8.5271 · Cited by 333 · cited 11× · see citing works
“Whereas stimulation of NOD1 and NOD2 (Figure 1), members of the NLR family, results primarily in the activation of the pro-inflammatory gene expression response (25), other NLRs (like NLRP3), activate the caspase-1 that processes the inactive IL-1β and IL-18 precursors and eventually results in the secretion of the IL…”
BackgroundInfluentialC-type lectins and phagocytosis
Kerrigan, A. M., & Brown, G. D. (2009) · Immunobiology · doi:10.1016/j.imbio.2008.11.003 · Cited by 325 · cited 1× · see citing works
“Other interesting reviews on RLRs or CLRs can be found elsewhere (6-12).”
BackgroundUnmet needs in modern vaccinology
Leroux-Roels, G. G. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.021 · Cited by 304 · cited 2× · see citing works
“The combination of adjuvants is thus a very promising approach and some formulations are already approved for human use, such as the vaccines against human papilloma virus (HPV) and hepatitis B virus combined with AS04 (Table 2) (52).”
BackgroundRole of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro.
Morefield, G. L., Sokolovska, A., Jiang, D., et al. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.07.050 · Cited by 298 · cited 7× · see citing works
“It has been shown that antigens adsorbed to alum are presented as a particulate form, enhancing internalization by APCs (42).”
BackgroundInfluentialYoun, J. H., Oh, Y. J., Kim, E. S., Choi, J. E., & Shin, J.-S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.5067 · Cited by 281 · cited 1× · see citing works
“Furthermore, HMGB1 can also mediate LPS transfer to CD14 to initiate a TLR4-mediated pro-inflammatory response, illustrating the complexity of interactions involving PAMPs, DAMPs and endogenous activators (18).”
BackgroundLectins as pattern recognition molecules: The effects of epitope density in innate immunity
Dam, T. K., & Brewer, C. F. (2009) · Glycobiology · doi:10.1093/glycob/cwp186 · Cited by 259 · cited 1× · see citing works
“Other interesting reviews on RLRs or CLRs can be found elsewhere (6-12).”
BackgroundAlum adjuvanticity: Unraveling a century old mystery
Gregorio, E. D., Tritto, E., & Rappuoli, R. (2008) · European Journal of Immunology · doi:10.1002/eji.200838648 · Cited by 232 · cited 1× · see citing works
“Aluminum salts (alum) were the first adjuvants licensed for human vaccines in the 1920’s and the licensure of novel adjuvants took about 80 years (4).”
BackgroundAkashi‐Takamura, S., & Miyake, K. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.07.001 · Cited by 215 · cited 1× · see citing works
“A complex composed of two copies of TLR4-MD-2-LPS initiates the cascade of intracellular signaling (17).”
BackgroundSokolovska, A., Hem, S., & Hogenesch, H. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.03.045 · Cited by 213 · cited 11× · see citing works
“Whereas stimulation of NOD1 and NOD2 (Figure 1), members of the NLR family, results primarily in the activation of the pro-inflammatory gene expression response (25), other NLRs (like NLRP3), activate the caspase-1 that processes the inactive IL-1β and IL-18 precursors and eventually results in the secretion of the IL…”
BackgroundInfluentialKerfoot, S. M., Long, E. M., Hickey, M. J., Andonegui, G., Lapointe, B. M., Zanardo, R. C. O., Bonder, C. S., James, W. G., Robbins, S. M., & Kubes, P. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.7070 · Cited by 208 · cited 1× · see citing works
“Although signaling through TLR4 has been implicated in the immunomodulation by PT (69-71), proliferation of lymphocytes can also be observed in TLR4 knockout mice, thus suggesting other routes of activation (72).”
BackgroundPrinciples of vaccine design-Lessons from nature.
Zepp, F. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.07.020 · Cited by 196 · cited 1×
“Vaccines can be composed of live attenuated organisms, killed whole-cell organisms or subunit components (3).”
BackgroundYellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
Barrett, A., & Teuwen, D. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.05.018 · Cited by 194 · cited 1×
“It induces a polyvalent immune response that includes the production of cytotoxic T cells, a mixed Th1/Th2 cell profile and neutralizing antibodies that can persist up to 40 years (36).”
BackgroundPoland, G. A., & Spier, R. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.02.052 · Cited by 166 · see citing works
Eskola, J., Ölander, R.-M., Hovi, T., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)04356-5 · Cited by 157 · cited 1×
“In contrast to wP, acellular pertussis vaccines, which are composed of pertussis proteins, including PT and FHA, have been shown to decrease the immune response to combined vaccines (74,75).”
BackgroundInnate instruction of adaptive immunity revisited: the inflammasome
Eisenbarth, S. C., & Flavell, R. A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900014 · Cited by 130 · cited 1× · see citing works
“For instance, NLRP3 can be activated by ATP and K+ efflux, by crystalline/particulate ligands and by reactive oxygen species (28).”
BackgroundNovel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants
Aimanianda, V., Haensler, J., Lacroix‐Desmazes, S., Kaveri, S. V., & Bayry, J. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.03.005 · Cited by 126 · cited 1× · see citing works
“CD80/CD86, CD40, CD54 and CD58 on APCs bind to CD28, CD154, CD11a, CD2 on T cells, respectively, establishing a complex and a close interaction (immunological synapse) between the cells (35).”
BackgroundPhilbin, V. J., & Levy, O. (2009) · Pediatric Research · doi:10.1203/pdr.0b013e31819f195d · Cited by 108 · cited 1× · see citing works
“Activation of the inflammasome by molecules recognized by NLRP3 will catalyze the processing of the IL-1β precursor induced by TLR-dependent mechanisms (26,30-32).”
BackgroundImmunodeficiency and Genetic Defects of Pattern-Recognition Receptors
Netea, M. G., & van der Meer, J. W. M. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001976 · Cited by 103 · cited 1× · see citing works
“Other interesting reviews on RLRs or CLRs can be found elsewhere (6-12).”
BackgroundThe Chase for the RIG-I Ligand—Recent Advances
Schlee, M., & Hartmann, G. (2010) · Molecular Therapy · doi:10.1038/mt.2010.90 · Cited by 98 · cited 1× · see citing works
“Other interesting reviews on RLRs or CLRs can be found elsewhere (6-12).”
BackgroundFedele, G., Spensieri, F., Palazzo, R., Nasso, M., Cheung, G. Y. C., Coote, J. G., & Ausiello, C. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008734 · Cited by 86 · cited 1× · see citing works
“pertussis proteins act by subverting the immune system during infection (62,63).”
BackgroundDagan, R., Goldblatt, D., Maleckar, J. R., et al. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5383-5391.2004 · Cited by 85 · cited 1×
“In contrast to wP, acellular pertussis vaccines, which are composed of pertussis proteins, including PT and FHA, have been shown to decrease the immune response to combined vaccines (74,75).”
BackgroundPotential adjuvantic properties of innate immune stimuli
Warshakoon, H. J., Hood, J. D., Kimbrell, M. R., Malladi, S. S., Wu, W. Y., Shukla, N. M., Agnihotri, G., Sil, D., & David, S. A. (2009) · Human Vaccines · doi:10.4161/hv.5.6.8175 · Cited by 83 · cited 1× · see citing works
“Other TLR agonists are also being tested for use as adjuvants, such as immunostimulatory molecules containg repeating sequences of cytosine phophoguanosine dinucleotides targeting TLR9 and the TLR7/8 agonists imiquimod and resiquimod (51).”
BackgroundPTX cruiser: driving autoimmunity via TLR4.
Racke, M., Hu, W., & Lovett-Racke, A. (2005) · Trends in immunology · doi:10.1016/j.it.2005.03.012 · Cited by 83 · cited 1×
“Although signaling through TLR4 has been implicated in the immunomodulation by PT (69-71), proliferation of lymphocytes can also be observed in TLR4 knockout mice, thus suggesting other routes of activation (72).”
BackgroundTLR4 agonists as immunomodulatory agents
Alderson, M. R., McGowan, P., Baldridge, J. R., & Probst, P. (2006) · Journal of Endotoxin Research · doi:10.1179/096805106x118753 · Cited by 80 · cited 11× · see citing works
“Furthermore, HMGB1 can also mediate LPS transfer to CD14 to initiate a TLR4-mediated pro-inflammatory response, illustrating the complexity of interactions involving PAMPs, DAMPs and endogenous activators (18).”
BackgroundInfluentialMielcarek, N., Riveau, G., Remoue, F., et al. (1998) · Nature Biotechnology · doi:10.1038/nbt0598-454 · Cited by 79 · cited 4×
“Single inoculation of FHA can induce total antibody production and the secretion of MIP-3α, a chemokine involved in the recruitment of dendritic cells to the site of inoculation.”
BackgroundInfluentialNasso, M., Fedele, G., Spensieri, F., Palazzo, R., Costantino, P., Rappuoli, R., & Ausiello, C. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901071 · Cited by 69 · cited 1× · see citing works
“Although signaling through TLR4 has been implicated in the immunomodulation by PT (69-71), proliferation of lymphocytes can also be observed in TLR4 knockout mice, thus suggesting other routes of activation (72).”
BackgroundOliveira, M. L. S., Miyaji, E. N., Ferreira, D. M., Moreno, A. T., Ferreira, P. C. D., Lima, F. A., Santos, F. L., Sakauchi, M. A., Takata, C. S., Higashi, H. G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010863 · Cited by 54 · cited 2× · see citing works
“Furthermore, the lower LPS content of wPlow did not significantly alter the adjuvant activity (61).”
BackgroundSelf-citationMcguirk, P., & Mills, K. (2000) · Infection and Immunity · doi:10.1128/iai.68.3.1383-1390.2000 · Cited by 52 · cited 5×
“In contrast to wP, acellular pertussis vaccines, which are composed of pertussis proteins, including PT and FHA, have been shown to decrease the immune response to combined vaccines (74,75).”
BackgroundInfluentialQuintilio, W., Kubrusly, F. S., Iourtov, D., et al. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.047 · Cited by 41 · cited 1×
“Moreover, this MPL combined with seasonal or pandemic influenza vaccines was effective in mice and was able to reduce the amount of antigen necessary for achieving protective titers (76,77).”
BackgroundSelf-citationMarr, N., Novikov, A., Hajjar, A., et al. (2010) · Journal of Infectious Diseases · doi:10.1086/657409 · Cited by 38
Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in Infants
Zorzeto, T. Q., Higashi, H. G., da Silva, M. T. N., et al. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00339-08 · Cited by 38 · cited 1×
“This new vaccine was shown to be safe and to induce similar immune responses in a phase I clinical trial and is a good candidate for replacing the classical wP (58).”
BackgroundSelf-citationReactive Oxygen Species Enhance TLR10 Expression in the Human Monocytic Cell Line THP-1
Kim, D. H., Kim, Y. J., Koh, H. S., Jang, T. Y., Park, H. E., & Kim, J. Y. (2010) · International Journal of Molecular Sciences · doi:10.3390/ijms11103769 · Cited by 36 · cited 2× · see citing works
“Mice do not present a functional TLR10 due to an insertional mutagenesis of a retrovirus but have additional TLRs (TLRs11-13), besides those in common with man (TLRs1-9).”
BackgroundThe duration of immunity in cattle following inoculation of rinderpest cell culture vaccine
Plowright, W. (1984) · Journal of Hygiene · doi:10.1017/s0022172400064524 · Cited by 34 · cited 1×
“Again, rinderpest in cattle is being eradicated through the use of an attenuated goat-adapted virus developed by Walter Plowright through serial passages of the pathogen in tissue culture (1).”
MethodMiyaki, C., Quintilio, W., Miyaji, E. N., Botosso, V. F., Kubrusly, F. S., Santos, F. L., Iourtov, D., Higashi, H. G., & Raw, I. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.01.044 · Cited by 33 · cited 1× · see citing works
“Moreover, this MPL combined with seasonal or pandemic influenza vaccines was effective in mice and was able to reduce the amount of antigen necessary for achieving protective titers (76,77).”
BackgroundSelf-citationFischer, J. E., Johnson, J. E., Johnson, T. R., & Graham, B. S. (2000) · The Journal of Infectious Diseases · doi:10.1086/315806 · Cited by 31 · cited 2× · see citing works
“The pertussis toxin (PT) is probably the best characterized among them and has been shown to increase immune responses against co-administered antigens both through the mucosal and parenteral routes of inoculation (64,68).”
BackgroundMcguirk, P., Johnson, P. A., Ryan, E., et al. (2000) · Journal of Infectious Diseases · doi:10.1086/315838 · Cited by 31 · cited 1×
“Interestingly, some of these components have already been described for their adjuvant properties when combined with antigens (64-67).”
BackgroundThe Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant properties
Munro, P. M., Flatau, G., Anjuère, F., Hofman, V., Czerkinsky, C. C., & Lemichez, E. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.11.042 · Cited by 22 · cited 1× · see citing works
“Interestingly, some of these components have already been described for their adjuvant properties when combined with antigens (64-67).”
BackgroundFischer, J. E., Johnson, T. R., Peebles, R., et al. (1999) · Journal of Infectious Diseases · doi:10.1086/314947 · Cited by 20 · cited 1×
“The pertussis toxin (PT) is probably the best characterized among them and has been shown to increase immune responses against co-administered antigens both through the mucosal and parenteral routes of inoculation (64,68).”
BackgroundAnimal science. Rinderpest, deadly for cattle, joins smallpox as a vanquished disease.
Normile, D. (2010) · Science · doi:10.1126/science.330.6003.435 · Cited by 19 · cited 1×
“This will be the first veterinary infectious disease and also the second human disease eliminated from the face of the planet (2).”
BackgroundExposing Viruses: RNA Patterns Sensed by RIG-I-like Receptors
Rehwinkel, J. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9384-7 · Cited by 19 · cited 1× · see citing works
“Other interesting reviews on RLRs or CLRs can be found elsewhere (6-12).”
BackgroundPertussis toxin activates adult and neonatal naive human CD4+ T lymphocytes
Tonon, S., Badran, B., Benghiat, F., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200535697 · Cited by 18 · cited 1×
“Although signaling through TLR4 has been implicated in the immunomodulation by PT (69-71), proliferation of lymphocytes can also be observed in TLR4 knockout mice, thus suggesting other routes of activation (72).”
BackgroundPoulain-Godefroy, O., Vendeville, C., Locht, C., et al. (2008) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00460.x · Cited by 6 · cited 2×
“The filamentous hemagglutinin (FHA) has also been shown to increase antibody responses towards different antigens when administered to mice through mucosal routes (67).”
BackgroundConfidence in vaccines in developing countries: social, cultural, economic and political influences
Mulholland, K., Korczak, V., & Tangcharoensathien, V. (2010) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2008.085712 · Cited by 4 · cited 1×
“This is an important concern for maintaining high levels of confidence in vaccines (78), which are usually greater among populations in developing countries than in industrialized countries (79).”
Background
Flagged first, then by citations
2 of the 81 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- McKee AS, Macleod MK, Kappler JW, Marrack P. Immune mechanisms of protection: can adjuvants rise to the chal- lenge? BMC Biol 2010; 8: 37.
- PAHO. Immunization newsletter. Edition Washington 2007; 1-8.
Cited by
Sorted by citations
Aiello, A., Farzaneh, F., Candore, G., Caruso, C., Davinelli, S., Gambino, C. M., Ligotti, M. E., Zareian, N., & Accardi, G. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02247 · Cited by 693 · see citing works
Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants
Tan, K., Li, R., Huang, X., & Liu, Q. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00783 · Cited by 193 · see citing works
“…and complete immunity, mucosal adjuvant and delivery vehicle High cost The presence of PAMPs; induction of danger molecules and the “geographic concept” Leo et al., 2015 of the antigen presenting cells (ACPs) and activate naïve T cells, thereby activating the immune system (Miyaji et al., 2011).”
BackgroundTargeted drug delivery to melanoma
Liu, Q., Das, M., Liu, Y., & Huang, L. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.016 · Cited by 138 · see citing works
Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines
Savelkoul, H. F. J., Ferro, V. A., Strioga, M. M., & Schijns, V. E. C. J. (2015) · Vaccines · doi:10.3390/vaccines3010148 · Cited by 89 · see citing works
Live bacterial vaccine vectors: An overview
da Silva, A. J., Zangirolami, T. C., Novo‐Mansur, M. T. M., Giordano, R. C., & Martins, E. A. L. (2014) · Brazilian Journal of Microbiology · doi:10.1590/s1517-83822014000400001 · Cited by 87 · see citing works
“These molecules recruit the APCs and are the key molecules linking the innate and adaptive immune systems (Miyaji et al., 2011).”
BackgroundEscamilla-Tilch, M., Filio‐Rodríguez, G., García‐Rocha, R., Mancilla‐Herrera, I., Mitchison, N. A., Ruiz‐Pacheco, J. A., Sánchez‐García, F. J., Sandoval‐Borrego, D., & Vázquez-Sánchez, E. A. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.58 · Cited by 86 · see citing works
Bacillus subtilis Spores as Vaccine Adjuvants: Further Insights into the Mechanisms of Action
Souza, R. D., Batista, M. T., Luiz, W. B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087454 · Cited by 83 · see citing works
“presentation of antigenic peptides bound to MHC molecules [6].”
BackgroundRummel, C. D. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.09.003 · Cited by 70 · see citing works
Jin, J., Tang, S. Q., Rong, M. Z., & Zhang, M. Q. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.08.002 · Cited by 70 · see citing works
Song, Z., Li, B., Zhang, Y., Li, R., Ruan, H., Wu, J. P., & Liu, Q. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01340 · Cited by 65 · see citing works
“This induction may be through pathogen-associated molecular patterns (PAMPs) on OMVs that can activate the immune system (Miyaji et al., 2011).”
BackgroundTargeting Natural Killer Cells for Improved Immunity and Control of the Adaptive Immune Response
Pierce, S. H., Geanes, E. S., & Bradley, T. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00231 · Cited by 58 · see citing works
“Pathogen-associated molecular patterns (PAMPs) are often incorporated as adjuvants in vaccines (Miyaji et al., 2011).”
BackgroundCyclic di‐nucleotides: new era for small molecules as adjuvants
Libanova, R., Becker, P. D., & Guzmán, C. A. (2011) · Microbial Biotechnology · doi:10.1111/j.1751-7915.2011.00306.x · Cited by 42 · see citing works
“Following PAMPs and DAMPs mediated triggering of the innate immune system via PRRs, the release of pro-inflammatory cytokines leads to the stimulation of the adaptive immune system (Miyaji et al., 2011).”
BackgroundInfluentialInflammasomes as Targets for Adjuvants
Ivanov, K., Garanina, E. E., Rizvanov, A. A., & Khaiboullina, S. F. (2020) · Pathogens · doi:10.3390/pathogens9040252 · Cited by 38 · see citing works
“It has been demonstrated that inflammasomes, which can recognize damage-associated molecular patterns (DAMPs), are also involved in the mechanisms of adjuvant action [24].”
BackgroundGrenfell, R. F. Q., Shollenberger, L. M., Samli, E. F., et al. (2015) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00714-14 · Cited by 33 · see citing works
“Maturation of APCs is essential for priming antigen-specific naive T cells, influencing both the magnitude and the type of the T and B cell responses as well as the induction of memory cells (2).”
Pyo, K., Lee, Y. W., Lim, S. M., & Shin, E. (2016) · Oncotarget · doi:10.18632/oncotarget.12316 · Cited by 32 · see citing works
“PAMPs trigger TLR signaling in APCs and have important roles in subsequent T cell differentiation and adaptive immunity [37].”
BackgroundLi, E., Yan, F., Huang, P., Chi, H., Xu, S., Li, G., Liu, C., Feng, N., Wang, H., Zhao, Y., et al. (2020) · Viruses · doi:10.3390/v12010125 · Cited by 30 · see citing works
Ren, B., Luo, S., Xu, F., Zou, G., Xu, G., He, J., Huang, Y., Zhu, H., & Li, Y. (2016) · Cell Stress and Chaperones · doi:10.1007/s12192-016-0758-5 · Cited by 26 · see citing works
“Lung cancer”
BackgroundHigh mobility group box 1 acts as an adjuvant for tuberculosis subunit vaccines
Grover, A., Troudt, J. M., Foster, C., Basaraba, R. J., & Izzo, A. A. (2013) · Immunology · doi:10.1111/imm.12236 · Cited by 25 · see citing works
Leishmaniasis: focus on the design of nanoparticulate vaccine delivery systems
Doroud, D., & Rafati, S. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.166 · Cited by 24 · see citing works
Systematic identification of small molecule adjuvants
Flower, D. R. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.699958 · Cited by 18 · see citing works
“PAMPs, either in purified form or synthetic PAMP analogues, can exert potent effects via pattern recognition receptors (PRRs), expressed on cells of the innate and adaptive systems [73].”
BackgroundImmunological Mechanism and Clinical Application of PAMP Adjuvants
Yan, Y., Yao, D., & Li, X. (2021) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/1574892816666210201114712 · Cited by 14 · see citing works
Jin, J., Peng, W. L., Tang, S. Q., Rong, M. Z., & Zhang, M. Q. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb02129e · Cited by 12 · see citing works
Inflammatory/Noninflammatory Adjuvants and Nanotechnology—The Secret to Vaccine Design
Wilson, K., Xiang, S. D., & Plebanski, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-39981-4.00006-3 · Cited by 9 · see citing works
Takagi, S., Takahashi, Y., Sugimura, K., et al. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2015.11.020 · Cited by 9 · see citing works
Antonoglou, M. B., Alberti, A. S., Redolfi, D. M., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01279 · Cited by 8 · see citing works
Droppa‐Almeida, D., da Silva, G. A., Gaspar, L. M. D. A. C., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256864 · Cited by 8 · see citing works
Sun, X., Hosomi, K., Shimoyama, A., et al. (2023) · International Immunology · doi:10.1093/intimm/dxad045 · Cited by 7 · see citing works
“Current candidate adjuvants include those carrying danger-associated molecular patterns and pathogen-associated molecular patterns (11).”
BackgroundBreaking the Bond: Recent Patents on Bacterial Adhesins
Carvalho, E., Ching, A. T. C., Abreu, P. A. E., et al. (2012) · Recent Patents on DNA & Gene Sequences · doi:10.2174/187221512801327352 · Cited by 7 · see citing works
“Several molecules from microorganisms, known as pathogen-associated molecular patterns (PAMPs), can be recognized through the binding to receptors from the innate immune system, the pattern recognition receptors (PRRs), leading to the stimulation of both the innate and adaptative immune responses [80].”
BackgroundSelf-citationImmunological effects of different types of synthetic CpG oligodeoxynucleotides on porcine cells
Li, R., Zhang, L., Shi, P., Deng, H., Li, Y. L., Ren, J., Fu, X., Zhang, L., & Huang, J. (2017) · RSC Advances · doi:10.1039/c7ra04493c · Cited by 7 · see citing works
Investigating toxicity specific to adjuvanted vaccines
Matsumoto, M., Komatsu, S.-I., Ikeda, T., Shimomura, K., Watanabe, K., Hirabayashi, K., Sawada, J., Maki, K., Shinoda, K., Fueki, O., et al. (2017) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2017.09.003 · Cited by 7 · see citing works
“…other candidates of PAMP 329 receptors expressed on APCs are C-type lectin receptors, nucleotide-binding oligomerization 330 domain and leucine-rich-repeat-containing receptors, and retinoic acid-inducible gene-1-like 331 receptors (Lavelle et al., 2010; Miyaji et al., 2011; Mahla et al., 2013).”
BackgroundJang, H.-E., Jung, H., & Mok, H. (2017) · Applied Biological Chemistry · doi:10.1007/s13765-017-0284-x · Cited by 6 · see citing works
“Recently, PAMPs have been popularly investigated as adjuvant materials [2, 3].”
BackgroundCorrea, V. A., Portilho, A. I., & Gaspari, E. D. (2022) · Diseases · doi:10.3390/diseases10030046 · Cited by 6 · see citing works
Sasaki, E., Asanuma, H., Momose, H., et al. (2025) · npj Vaccines · doi:10.1038/s41541-025-01086-0 · Cited by 3 · see citing works
“Since alum and AddaVax are known to induce slight cytotoxicity and are DAMP-inducible adjuvants 36,37 , it is speculated that base materials #1 – 8 are also DAMP-inducible adjuvants.”
Modified dipeptide based nanospheres as a potent adjuvating delivery system for recombinant vaccines
Biswas, S., Yadav, N., Somanathan, A., Mukherjee, P., & Chauhan, V. S. (2023) · Frontiers in Drug Delivery · doi:10.3389/fddev.2023.1135209 · Cited by 3 · see citing works
“Despite being safer, recombinant proteins are poor immunogens and require adjuvants added to the vaccine formulation to enhance the immune responses and provide greater defense against the target pathogen (Miyaji et al., 2011; Reed et al., 2013).”
BackgroundThe Immune System as Drug Target
Flower, D. R. (2013) · Immunology and Immunogenetics Insights · doi:10.4137/iii.s12145 · Cited by 3 · see citing works
(2021) · Frontiers research topics · doi:10.3389/978-2-88966-718-5 · Cited by 3 · see citing works
Masriadi1, H. H. I. (2020) · Indian Journal of Forensic Medicine & Toxicology · doi:10.37506/ijfmt.v14i4.12325 · Cited by 2 · see citing works
Towards the Systematic Discovery of Immunomodulatory Adjuvants
Flower, D. R. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5070-2_9 · Cited by 2 · see citing works
Introductory Chapter: Immunization - Vaccine Adjuvant Delivery System and Strategies
Wang, N., & Wang, T. (2018) · IntechOpen eBooks · doi:10.5772/intechopen.81981 · Cited by 2 · see citing works
“However, unfortunately, subunit vaccines often have a rather weak immunogenicity, due to lack of the immunostimulatory components broadly shared by pathogens while being distinguishable from host molecules, which are collectively referred to as pathogen-associated molecular patterns (PAMPs) [15] able to bind to and tr…”
BackgroundAcción adyuvante de esporas de Bacillus subtilis por vía mucosa
Tub-Chafer, F., Reyes-Díaz, L. M., Vega-García, I. G., et al. (2016) · Vaccimonitor/VacciMonitor · Cited by 1 · see citing works
[Correlation between pathogen-associated molecular patterns and periodontitis].
Xin, Y., Yue, H., Qi, T., et al. (2016) · PubMed · doi:10.7518/hxkq.2016.01.019 · Cited by 1 · see citing works
Roles in innate immune receptors: Host : pathogen interactions and strengthening vaccines
Nyström, S. (2013) · Figshare
Soares, B. A., Ságio, S. A., Peconick, A. P., et al. (2014) · Pesquisa Veterinária Brasileira · doi:10.1590/s0100-736x2014000300004
Agostinho, D., & Ribeiro, M. (2013)
A Quick and Simple Polarographic Method for Aluminum Measurement in Recombinant Hepatitis B Vaccine
Alebouyeh, M. R., Abedi, Z., Rastegar, H., et al. (2015) · Medical Laboratory Journal · doi:10.18869/acadpub.mlj.9.5.16
“Hepatitis B virus surface antigen (HBsAg) has several antigenic epitopes binding to aluminum adjuvants through ligand switching mechanism (1-5).”
BackgroundMethodFACULDADE DE CIÊNCIAS FARMACÊUTICAS Programa de Pós-Graduação em Farmácia Área de Análises Clínicas
Ostermayer, P., & Casale, A. (2013)
Different Platforms, Immune Response Modulators and Challenges in SARS-CoV-2 Vaccination
Portilho, A. I., Correa, V. A., Gaspar, E. B., & Gaspari, E. D. (2022) · Springer eBooks · doi:10.1007/978-3-031-08045-6_26
Madera, R. (2012) · eScholarship@UMassChan · doi:10.13028/fcrm-mf40
“immune triggers: PAMPs and damage-associated molecular patterns (DAMPs) (114) that can stimulate the immune system through PRR activation in APCs such DCs and indirectly by PRR activation in bystander cells (Figure 6.”
- Authors
- Miyaji, E. N., Carvalho, E., Oliveira, M. L. S., Raw, I., & Ho, P. L.
- Affiliations
- Instituto Butantan (BR)
- Venue
- Brazilian Journal of Medical and Biological Research
- Publisher
- FapUNIFESP (SciELO)
- Published
- 2011-06
- Volume
- 44
- Issue
- 6
- Pages
- 500-513
- ISSN
- 0100-879X (ISSN-L)
- 1414-431X
- OpenAlex
- W2002280987
- Cited by
- 66
- References
- 81
- Citations by year
- 2025: 1 · 2023: 4 · 2022: 4 · 2021: 6 · 2020: 6 · 2019: 2 · 2018: 5 · 2017: 6 · 2016: 7 · 2015: 4 · 2014: 5 · 2013: 8 · 2012: 4
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Brazilian Journal of Medical and Biological Research (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- Americanae (AECID Library) (submittedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
- Fundação Butantan
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Keywords
- vaccine adjuvants, damage-associated molecular patterns, pathogen-associated molecular patterns, innate immune recognition, innate immunity, adaptive immunity, aluminum salts, vaccine development
- MeSH terms
- Adjuvants, Immunologic, Animals, Humans, Immunity, Cellular, Immunity, Innate, Pertussis Vaccine, Vaccines, Vaccines, Attenuated, Aluminum Compounds, Virulence Factors, Receptors, Pattern Recognition, Toll-Like Receptors, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review